Comorbid depressive and anxiety disorders in patients with cancer

Der Nervenarzt
H-P Kapfhammer

Abstract

Patients with cancer face a high risk of comorbid depressive and anxiety disorders that have to be paradigmatically considered within a complex biopsychosocial context. Several conceptual challenges have to be mastered in arriving at a correct clinical diagnosis. Coexistent affective and anxiety disorders in cancer patients include a more dramatic subjective suffering, reduced psychological coping, possible negative interference with somatic treatment and rehabilitation, impaired quality of life and higher grades of psychosocial disability. They may also lead to an overall increased risk of somatic morbidity, a more rapid progression of cancer and a higher cancer-related mortality in the course of the disease. Manifold psychological, psychosocial and existential, cancer and treatment-related stressors have to be considered with respect to common neurobiological, especially neuroendocrine and neuroinflammatory mechanisms. Complex psychosomatic, somatopsychic and somato-somatic effects must always be considered. Evidence-based approaches in psychotherapy and pharmacotherapy exist for the integrative treatment of comorbid depressive and anxiety disorders in cancer.

References

Dec 23, 1998·Journal of the National Cancer Institute·B W PenninxR J Havlik
Jan 9, 2001·JAMA : the Journal of the American Medical Association·W BreitbartR Brescia
Mar 5, 2003·American Journal of Epidemiology·Kirsi LillbergMarkku Koskenvuo
Jul 13, 2004·Clinical Psychology Review·Bert Garssen
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Erlend HemØivind Ekeberg
Nov 17, 2005·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Maria KangasRichard A Bryant
Dec 1, 2007·Psycho-oncology·Daniel T RasicJitender Sareen
May 22, 2008·Nature Clinical Practice. Oncology·Yoichi ChidaAndrew Steptoe
Oct 11, 2008·Nature Reviews. Cancer·Bostjan SerugaIan F Tannock
Oct 24, 2008·Psycho-oncology·Barry J A LairdMarie T Fallon
Feb 24, 2009·Journal of Psychosomatic Research·Mark HamerGerard J Molloy
Nov 4, 2009·Cancer Causes & Control : CCC·Alden L GrossWilliam W Eaton
Jan 21, 2010·Psychological Medicine·M Pinquart, P R Duberstein
Mar 10, 2010·Psycho-oncology·Anna RobsonFiona MacLeod
Sep 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ebrahim HaroonAndrew H Miller
Oct 25, 2011·Psychosomatic Medicine·Susan K Lutgendorf, Anil K Sood
Nov 30, 2011·Pharmacology·C Miguel, E Albuquerque
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lara TraegerWilliam F Pirl
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Madeline LiGary Rodin
Nov 24, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J WalkerM Sharpe
Jan 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hermann FallerRoland Küffner
Jun 19, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W BoyesMariko L Carey
Jul 6, 2013·Psychotherapie, Psychosomatik, medizinische Psychologie·Anja MehnertUwe Koch
Nov 13, 2013·Annual Review of Medicine·M Beatriz Currier, Charles B Nemeroff
Dec 7, 2013·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Cecilie E KiserudSophie D Fosså
Feb 20, 2014·British Journal of Cancer·C S D Roxburgh, D C McMillan
Apr 11, 2014·International Review of Psychiatry·Ingrid Barrera, David Spiegel
Apr 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara L AndersenUNKNOWN American Society of Clinical Oncology
Jul 18, 2014·Psychological Medicine·L TecutaG A Fava
Oct 8, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anja MehnertUwe Koch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater
Hans-Peter Kapfhammer
Annals of the New York Academy of Sciences
C B NemeroffJ Berger
Advances in Mind-body Medicine
Tatjana Sivik, Rebecca Schoenfeld
Advances in Mind-body Medicine
Tatjana Sivik, Rebecca Schoenfeld
© 2022 Meta ULC. All rights reserved